Abstract Recently updated American Society of Clinical Oncology (ASCO) guidelines for
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy (CIPN) in …

Background As the number and type of cancer treatments available rises and patients live
with the consequences of their disease and treatments for longer, understanding …

PURPOSE The coronavirus disease 2019 (COVID-19) pandemic has imposed a unique
challenge to oncology patients and their treatment. There is no study related to the patients' …

Background: Real-time, rapid assessment of barriers to care experienced by patients can be
used to inform relevant health care legislation. In recent years, online communities have …

Introduction Treatment advances for metastatic breast cancer (mBC) have improved overall
survival (OS) in some mBC subtypes; however, there remains no cure for mBC. Considering …

Background: We used the Therapy Preference Scale, a 30-item questionnaire, to determine
cancer treatment preferences of adults with cancer. Methods: We used Wilcoxon's rank sum …

Introduction Understanding how patients value different characteristics of an intervention
and make trade-offs in a therapy choice context with potential benefit and possible harm …

Purpose Clinical practice guidelines recommend altering neurotoxic chemotherapy
treatment in patients experiencing intolerable chemotherapy-induced peripheral neuropathy …

Introduction The purpose of this investigation was to explore patients' and oncologists'
preferences for the characteristics of a pharmacological regimen for patients with advanced …

Simple Summary Identifying and understanding patient preferences regarding their own
care can help to tailor cancer therapies and services to the needs, goals, and values of …